Know Cancer

forgot password

Confocal Reflectance Microscopy of Shave-Biopsy Sites on Skin in Vivo

18 Years
80 Years
Open (Enrolling)
Basal Cell Carcinoma, Melanoma, Squamous Cell Carcinoma, Non-Malignant Skin Disorders

Thank you

Trial Information

Confocal Reflectance Microscopy of Shave-Biopsy Sites on Skin in Vivo

Inclusion Criteria:

- Patients undergoing shave-biopsy on an anatomical site that is readily accessible to
the VivaScope 1500 (for example, chest, back, legs, arms, cheek, forehead).

- Ability to sign informed consent.

- Age > 18 years.

Exclusion Criteria:

- Shave-biopsy located on a site that is not amenable to confocal imaging (for example,
adjacent to the nose, ears or eyes, fingers, toes).

- Inability to give informed consent.

- Known hypersensitivity to adhesive rings.

- Inability to tolerate imaging procedure (i. e., remain relatively still for multiple
short durations of 3-4 minutes).

Type of Study:


Study Design:

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

is to evaluate and quantify the technical feasibility of reflectance CSLM imaging of shave-biopsy sites on skin in vivo.

Outcome Time Frame:

conclusion of study

Safety Issue:


Principal Investigator

Kishwer Nehal, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center


United States: Institutional Review Board

Study ID:




Start Date:

February 2006

Completion Date:

January 2014

Related Keywords:

  • Basal Cell Carcinoma
  • Melanoma
  • Squamous Cell Carcinoma
  • Non-Malignant Skin Disorders
  • Carcinoma
  • Carcinoma, Basal Cell
  • Carcinoma, Squamous Cell
  • Melanoma
  • Skin Diseases



Memorial Sloan Kettering Cancer Center New York, New York  10021